Intrinsiqq
Regeneron Pharmaceuticals, Inc. logo

Regeneron Pharmaceuticals, Inc.

REGN

Compare

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap$96.74B
EPS$45.30
P/E20.22
P/FCF25.28
EV/EBITDA16.76
FCF Yield4.0%
Div. Yield0.40%
Net Debt/FCF-1.7x
Regeneron Pharmaceuticals, Inc. intrinsic value
52-Week Range
$600.66$973.36

Profitability & Returns

Revenue (TTM)

$16.90B

▲ +1.0% YoY

Net Income (TTM)

$4.82B

▲ +2.1% YoY

Op. Margin

28.79%

▼ -3.2pp YoY

ROIC

11.50%

▼ -3.3pp YoY

Cash Flow & Balance Sheet

FCF (TTM)

$3.83B

▲ +11.3% YoY

Op. Cash Flow (TTM)

$4.85B

▲ +12.6% YoY

Net Debt

-$6.59B

Net Cash Position

Cash & Equiv.

$9.30B

5Y CAGR: +11.0%

5Y CAGR: +15.3%

Continue Research

Peers

Pharmaceutical Preparations · Pick stocks to compare with REGN

CompareIntrinsic value
TEVATeva Pharmaceutical Industries Ltd
$42.40-1.33%40
UPCUniverse Pharmaceuticals Inc.
$1.55-3.13%39
VTRSViatris Inc.
$20.85+1.76%24
VRTXVertex Pharmaceuticals Incorporated
$547.85-0.55%46
BHCBausch Health Companies Inc.
$8.29-1.31%56
ZTSZoetis Inc.
$82.45+0.16%76
ONCBeOne Medicines Ltd.
$424.00+1.60%67
OGNOrganon & Co.
$13.89+0.29%28

Held by ETFs

REGN is in 366 US ETFs. The largest of them, with REGN's weight in each:

Regeneron Pharmaceuticals (REGN) in four numbers

Fair value (earnings)
$530.17
Price $916.06 is 73% above it.
Intrinsic Value
Quality score
54/100
Best check: share count change, -7.0%. Weakest: margin trend, -10.1pp.
Quality
Dividend (TTM)
$3.59
0.40% yield, not raised in the latest year.
Dividends
P/E
20.22
Price to free cash flow 25.28.
Financials

Questions about Regeneron Pharmaceuticals

Is Regeneron Pharmaceuticals (REGN) overvalued?

At $916.06, Regeneron Pharmaceuticals' price is 73% above the $530.17 a share fair value that Intrinsiqq's calculator gets from its earnings. It trades at 20.22 times earnings and 25.28 times free cash flow. The growth behind that figure is yours to set on the Intrinsic Value tab. See how to tell if a stock is overvalued.

What is Regeneron Pharmaceuticals' fair value?

Intrinsiqq's calculator puts Regeneron Pharmaceuticals' fair value at $530.17 a share. It grows earnings per share 1.2% a year for 5 years, applies an exit P/E of 19.7, and works back at a 10% yearly return. A 25% margin of safety gives a buy-below price of $397.63. Every input can be changed on the Intrinsic Value tab.

Is Regeneron Pharmaceuticals a high-quality business?

Regeneron Pharmaceuticals scores 54 out of 100 on Intrinsiqq's quality score, which makes it a mixed business on these measures. The score blends 8 checks computed from SEC filings. Its best check is share count change at -7.0%, and its weakest is margin trend at -10.1pp. The Quality tab shows every check against its target.

Does Regeneron Pharmaceuticals (REGN) pay a dividend, and how much?

Yes. Regeneron Pharmaceuticals (REGN) pays a dividend: $3.59 per share over the last twelve months, a dividend yield of 0.40% at the latest close. The payout takes about 8.0% of earnings. The Dividends tab has the full payment history and the safety score.

Source: 10-Q filed 30 Oct 2026 (period ending 30 Sept 2026), SEC. Price: last close 10 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong? Check it in REGN's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing REGN

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.